Kush Parmar's Net Worth

$183 Million

Estimate Recalculated May 10, 2024 03:40PM EST

Who is Kush Parmar?

Kush Parmar has an estimated net worth of $183 Million. This is based on reported shares across multiple companies, which include Enliven Therapeutics, Inc., Skye Bioscience, Inc., CinCor Pharma, Inc., Entrada Therapeutics, Inc., Vor Biopharma Inc., Rallybio Corp, ARVINAS, INC., 5:01 Acquisition Corp., IMPEL NEUROPHARMA INC, scPharmaceuticals Inc., Cabaletta Bio, Inc., Akouos, Inc., Homology Medicines, Inc., Audentes Therapeutics, Inc., and Aprea Therapeutics, Inc..

SEC CIK

Kush Parmar's CIK is 0001664281

Past Insider Trading and Trends

2021 was Kush Parmar's most active year for acquiring shares with 26 total transactions. Kush Parmar's most active month to acquire stocks was the month of May. 2021 was Kush Parmar's most active year for disposing of shares, totalling 26 transactions. Kush Parmar's most active month to dispose stocks was the month of October. 2022 saw Kush Parmar paying a total of $25,520,000.00 for 5,019,687 shares, this is the most they've acquired in one year. In 2019 Kush Parmar cashed out on 7,945,433 shares for a total of $13,204,050.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Skye Bioscience, Inc. (SKYE) Snapshot price: $4.98

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+5.66%
450K
$10.00
$4,500,000.00
8.39M
Mar 13
Form 4
+190.18%
5.21M
$2.31
$12,026,030.94
7.94M
Jan 31
Form 3
—
0
—
—
0
No matching records found

IMPEL NEUROPHARMA INC (IMPL) Snapshot price: $0.05

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.88M
$14.25
$8,625,000.00
2.88M
Apr 27
Form 4
—
0
—
—
0
Apr 22
Form 3
—
0
—
—
0
No matching records found

Cabaletta Bio, Inc. (CABA) Snapshot price: $23.79

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-12.50%
-295.00K
$13.00
-$3,835,000.00
2.06M
Nov 1
Form 4
-23.90%
-625.00K
$9.70
-$6,062,500.00
1.99M
Sep 7
Form 4
-6.01%
-387.00K
$13.00
-$5,031,000.00
6.05M
Jan 8 - Jan 12
Form 4
-8.12%
-298.00K
$14.75
-$4,395,500.00
3.37M
Dec 10
Form 4
∞
3.67M
$11.00
$4,999,995.00
3.67M
Oct 29
Form 3
—
0
—
—
0
No matching records found

Aprea Therapeutics, Inc. (APRE) Snapshot price: $6.713

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-55.82%
-175.00K
$25.30
-$4,427,500.00
138.5K
Oct 5
Form 4
-5.95%
-140.00K
$33.30
-$4,662,000.00
2.21M
Jun 16
Form 4
-10.82%
-245.00K
$28.75
-$7,044,411.50
2.02M
Jun 11
Form 4
-10.12%
-255.00K
$35.15
-$8,963,250.00
2.26M
May 19
Form 4
+140.66%
2.84M
$15.00
$4,999,995.00
4.86M
Oct 7
No matching records found

Enliven Therapeutics, Inc. (ELVN) Snapshot price: $15.35

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-17.70%
-825.00K
$14.90
-$12,292,500.00
3.84M
Feb 14
Form 4
-9.69%
-500.00K
$15.00
-$7,500,000.00
4.66M
Jan 31
Form 4
-3.69%
-197.50K
$15.00
-$2,962,500.00
5.16M
Sep 26
Form 4
-7.59%
-440.00K
$16.00
-$7,040,000.00
5.36M
Aug 24
Form 3
—
0
—
—
0
No matching records found